🔗 Share this article

This year's prestigious award in medical science was granted for revolutionary discoveries that clarify how the body's defense network targets dangerous pathogens while sparing the healthy tissues.

A trio of renowned researchers—Japan's Prof. Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—share this accolade.

The research uncovered specialized "sentinels" within the defense system that remove malfunctioning immune cells that could attacking the body.

These findings are now paving the way for new treatments for immune disorders and cancer.

The laureates will share a prize fund valued at 11 million SEK.

Decisive Discoveries

"Their work has been decisive for comprehending how the immune system operates and the reason we don't all suffer from severe self-attack conditions," commented the head of the award panel.

This trio's research address a core question: How does the immune system defend us from countless invaders while keeping our own tissues intact?

Our body's protection system uses immune cells that search for indicators of infection, even pathogens and bacteria it has not met before.

Such cells utilize detectors—called recognition units—that are produced by chance in countless combinations.

That provides the immune system the capacity to fight a wide array of threats, but the randomness of the mechanism inevitably produces immune cells that may attack the host.

Protectors of the Immune System

Researchers earlier understood that a portion of these harmful white blood cells were eliminated in the thymus—the site where white blood cells develop.

This year's award honors the discovery of T-reg cells—described as the body's "peacekeepers"—which travel through the system to neutralize any immune cells that attack the body's own tissues.

It is known that this process malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The Nobel panel stated, "These discoveries have laid the foundation for a new field of investigation and spurred the development of innovative treatments, for instance for cancer and autoimmune diseases."

Regarding malignancies, T-regs block the body from attacking the tumor, so studies are focused on lowering their quantity.

In self-attack disorders, trials are exploring boosting regulatory T-cells so the body is not being harmed. A similar method could also be useful in minimizing the risks of organ transplant rejection.

Pioneering Studies

Professor Shimon Sakaguchi, from Osaka University, conducted tests on rodents that had their immune gland extracted, leading to self-attack conditions.

He showed that injecting immune cells from healthy animals could prevent the disease—suggesting there was a system for blocking immune cells from harming the host.

Mary Brunkow, from the Institute for Systems Biology in a US city, and Dr. Ramsdell, now at a biotech firm in a California city, were investigating an inherited autoimmune disease in mice and humans that resulted in the identification of a genetic factor vital for the way regulatory T-cells function.

"Their groundbreaking work has uncovered how the immune system is controlled by regulatory T cells, stopping it from accidentally attacking the healthy cells," said a leading biological science specialist.

"This research is a remarkable example of how fundamental biological research can have broad consequences for human health."